Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect
Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry
JAK inhibitors prevent JAK activation. The signaling cascade that... | Download Scientific Diagram
Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
JAK Inhibitor 瑞石生物医药有限公司
After 25 years of drug development, do we know JAK? | RMD Open
Current and future status of JAK inhibitors - The Lancet
JAK阻害 | JAK Inhibition
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis - Wood - 2022 - International Journal of Dermatology - Wiley Online Library
Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor | Journal of Medicinal Chemistry
Overview of small molecule inhibitors targeting the p38 MAPK pathway... | Download Scientific Diagram
JAK inhibitors and COVID-19 | Journal for ImmunoTherapy of Cancer
User's guide to JAK inhibitors in inflammatory bowel disease - ScienceDirect
JAK Inhibitors: Prospects in Connective Tissue Diseases | SpringerLink
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors - ScienceDirect
The emerging safety profile of JAK inhibitors in rheumatic disease | Nature Reviews Rheumatology
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology
Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata | Actas Dermo-Sifiliográficas
Selective Janus kinase inhibitors come of age | Nature Reviews Rheumatology
Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata | Actas Dermo-Sifiliográficas
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library
